RCUSArcus Biosciences

Median target
$42
calls from the last 12 months
Implied return
+64.4%
median target vs. price
Coverage
13 analysts · 14 calls
updated in the last 12 months
Consensus
10/3/0+10 net
Buy / Hold / Sell

Which analysts are behind RCUS's consensus?

See every current rating, price target and the analysts' track records for Arcus Biosciences — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 13 analysts with calls on RCUS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

RCUS elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-21InsidersAzoy AlexanderChief Accounting OfficerInsider sale2.8K sh @ $30.00 · planned trade$85K
2025-07-23ExecutiveTrump, Donald JPresidentPurchaseARCUS BIOSCIENCES INC$15,001 - $500,007
2025-04-28ExecutiveTrump, Donald JPresidentSaleARCUS BIOSCIENCES INC$1,001 - $150,004
2025-03-27ExecutiveTrump, Donald JPresidentPurchaseARCUS BIOSCIENCES INC$15,001 - $500,003
2025-02-24ExecutiveTrump, Donald JPresidentSaleARCUS BIOSCIENCES INC$1,001 - $150,002
2025-02-05ExecutiveTrump, Donald JPresidentPurchaseARCUS BIOSCIENCES INC$1,001 - $15,000
2025-01-30ExecutiveTrump, Donald JPresidentPurchaseARCUS BIOSCIENCES INC$1,001 - $150,001

More: insider activity · executive branch · trending